Institut Pasteur

pasteur.fr

Total trials

126

Active

41

Phase 3

5

Total enrollment

952,568

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 7 of 7 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
ROCEPHIN, metronidazole, RIFADIN, IZILOX, placebo combination therapy1
Lymecyclin and corresponding placebos of the experimental arm1
Probiotic1
blood samples collection1
Nasopharyngeal swab1
Blood samples1
Blood sample collection1

Next readouts

  • 2024-07-31
  • 2025-11-16
  • 2026-03-15
  • 2026-04-30
  • 2027-02-28

Top conditions

  • COVID-196
  • Dengue5
  • Arbovirus Infections4
  • Chikungunya4
  • Leptospirosis4
  • Healthy Volunteers4
  • Zika3
  • Bordetella Pertussis, Whooping Cough3

Frequently asked questions about Institut Pasteur

How many clinical trials does Institut Pasteur have on ClinicalTrials.gov?
Institut Pasteur is listed as the lead sponsor on 126 clinical trials in ClinicalTrials.gov, 41 of which are currently active (recruiting, enrolling, or ongoing).
How many of Institut Pasteur's trials are in Phase 3?
5 of Institut Pasteur's trials are in Phase 3, spread across 7 active drug programs.
What therapeutic areas does Institut Pasteur focus on?
Institut Pasteur's most-studied conditions on ClinicalTrials.gov are COVID-19, Dengue, Arbovirus Infections, Chikungunya, Leptospirosis.
When are Institut Pasteur's next clinical trial readouts?
Institut Pasteur has 5 upcoming primary-completion readouts tracked here; the soonest is “Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal”, expected around 2024-07-31.